These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27680685)

  • 1. CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity.
    Loyher PL; Rochefort J; Baudesson de Chanville C; Hamon P; Lescaille G; Bertolus C; Guillot-Delost M; Krummel MF; Lemoine FM; Combadière C; Boissonnas A
    Cancer Res; 2016 Nov; 76(22):6483-6494. PubMed ID: 27680685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
    Fei L; Ren X; Yu H; Zhan Y
    Front Immunol; 2021; 12():771210. PubMed ID: 34804061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
    Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH
    Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance.
    Mondini M; Loyher PL; Hamon P; Gerbé de Thoré M; Laviron M; Berthelot K; Clémenson C; Salomon BL; Combadière C; Deutsch E; Boissonnas A
    Cancer Immunol Res; 2019 Mar; 7(3):376-387. PubMed ID: 30696630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression.
    Sebastiani G; Ventriglia G; Stabilini A; Socci C; Morsiani C; Laurenzi A; Nigi L; Formichi C; Mfarrej B; Petrelli A; Fousteri G; Brusko TM; Dotta F; Battaglia M
    Sci Rep; 2017 Jul; 7(1):6897. PubMed ID: 28761107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary CCR2
    Milger K; Yu Y; Brudy E; Irmler M; Skapenko A; Mayinger M; Lehmann M; Beckers J; Reichenberger F; Behr J; Eickelberg O; Königshoff M; Krauss-Etschmann S
    Thorax; 2017 Nov; 72(11):1007-1020. PubMed ID: 28780502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
    Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
    J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
    Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paternal antigen-specific proliferating regulatory T cells are increased in uterine-draining lymph nodes just before implantation and in pregnant uterus just after implantation by seminal plasma-priming in allogeneic mouse pregnancy.
    Shima T; Inada K; Nakashima A; Ushijima A; Ito M; Yoshino O; Saito S
    J Reprod Immunol; 2015 Apr; 108():72-82. PubMed ID: 25817463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
    Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
    J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR2 Regulates the Immune Response by Modulating the Interconversion and Function of Effector and Regulatory T Cells.
    Bakos E; Thaiss CA; Kramer MP; Cohen S; Radomir L; Orr I; Kaushansky N; Ben-Nun A; Becker-Herman S; Shachar I
    J Immunol; 2017 Jun; 198(12):4659-4671. PubMed ID: 28507030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
    Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
    PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
    Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
    Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4.
    Zhang B; Jia H; Liu J; Yang Z; Jiang T; Tang K; Li D; Huang C; Ma J; Shen GX; Ye D; Huang B
    J Immunol; 2010 Dec; 185(12):7199-206. PubMed ID: 21068404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ag and IL-2 immune complexes efficiently expand Ag-specific Treg cells that migrate in response to chemokines and reduce localized immune responses.
    Hamano R; Baba T; Sasaki S; Tomaru U; Ishizu A; Kawano M; Yamagishi M; Mukaida N
    Eur J Immunol; 2014 Apr; 44(4):1005-15. PubMed ID: 24338997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
    Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA
    Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model.
    Wu L; Yun Z; Tagawa T; Rey-McIntyre K; Anraku M; de Perrot M
    J Thorac Oncol; 2011 Sep; 6(9):1578-86. PubMed ID: 21642867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.